NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · IEX Real-Time Price · USD
8.17
-0.39 (-4.56%)
At close: May 17, 2024, 4:00 PM
8.22
+0.05 (0.61%)
After-hours: May 17, 2024, 4:59 PM EDT
NeuroPace Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NeuroPace stock have an average target of 17, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 108.08% from the current stock price of 8.17.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NeuroPace stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 3 | 3 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $18 | Buy | Reiterates | $18 | +120.32% | May 9, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $16 → $20 | Hold → Buy | Upgrades | $16 → $20 | +144.80% | Mar 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $9 → $17 | Buy | Maintains | $9 → $17 | +108.08% | Mar 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +120.32% | Mar 6, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $13 | Hold | Maintains | $9 → $13 | +59.12% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
76.71M
from 65.42M
Increased by 17.25%
Revenue Next Year
90.16M
from 76.71M
Increased by 17.54%
EPS This Year
-1.18
from -1.27
EPS Next Year
-1.04
from -1.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 80.4M | 96.7M | 131.0M | 161.0M | 229.3M |
| Avg | 76.7M | 90.2M | 109.7M | 156.4M | 211.8M |
| Low | 71.5M | 81.6M | 91.8M | 150.3M | 192.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.9% | 26.1% | 45.3% | 46.8% | 46.6% |
| Avg | 17.3% | 17.5% | 21.6% | 42.6% | 35.4% |
| Low | 9.4% | 6.4% | 1.9% | 37.1% | 23.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.12 | -0.53 | 0.20 | -0.30 | 0.29 |
| Avg | -1.18 | -1.04 | -0.68 | -0.30 | 0.29 |
| Low | -1.21 | -1.23 | -1.04 | -0.28 | 0.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.